Gaurav Maini
Stock Analyst at LifeSci Capital
(3.11)
# 2,515
Out of 4,355 analysts
25
Total ratings
66.7%
Success rate
12.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gaurav Maini
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SION Sionna Therapeutics | Maintained: Buy | $60 | $42.82 | +40.12% | 7 | May 27, 2026 | |
| TENX Tenax Therapeutics | Maintained: Buy | $27 | $11.87 | +127.46% | 5 | May 16, 2026 | |
| TECX Tectonic Therapeutic | Maintained: Buy | $88 | $31.17 | +182.37% | 6 | May 16, 2026 | |
| LQDA Liquidia | Maintained: Buy | $71 | $61.86 | +14.78% | 3 | May 16, 2026 | |
| IKT Inhibikase Therapeutics | Maintained: Buy | $5 | $1.75 | +185.71% | 4 | May 16, 2026 |
Sionna Therapeutics
May 27, 2026
Maintained: Buy
Price Target: $60
Current: $42.82
Upside: +40.12%
Tenax Therapeutics
May 16, 2026
Maintained: Buy
Price Target: $27
Current: $11.87
Upside: +127.46%
Tectonic Therapeutic
May 16, 2026
Maintained: Buy
Price Target: $88
Current: $31.17
Upside: +182.37%
Liquidia
May 16, 2026
Maintained: Buy
Price Target: $71
Current: $61.86
Upside: +14.78%
Inhibikase Therapeutics
May 16, 2026
Maintained: Buy
Price Target: $5
Current: $1.75
Upside: +185.71%